Daniel Hollander, M.D. to Lead Innovative Research Effort
Funding Available to Expand on Recent Advances in Crohn's Disease Research
Daniel Hollander, M.D. has been named the Director of the program.
is a widely recognized expert in this field for his
visionary work on IBD.
I am honored that he
is committing his
time and efforts to finding improved therapy and prevention of IBD."
"In light of recent genetic discoveries regarding Crohn's disease, I am excited about the opportunities these grants will provide to investigators working in IBD research," Dr. Hollander
Hollander is a Professor of Medicine at the University of California, Los Angeles School of Medicine.
Before joining the BMRP, he was President/CEO of the Harbor-UCLA Research and Education Institute.
Hollander has held several academic leadership positions including: Executive Dean and Professor of Medicine at the University of Kansas School of Medicine, and Professor of Medicine and Head, Division of Gastroenterology at the University of California, Irvine (UCI).
While at UCI, he also served as Associate Dean for Research and Program Development, Associate Dean for Academic Affairs and Senior Associate Dean for Clinical Affairs.
Hollander is a member of the American Society for Clinical Investigation, the American College of Physicians, the American Federation for Medical Research, the American Gastroenterological Association, the American Physiological Society and the Western Association of Physicians.
He is a diplomate of the American Board of Internal Medicine and the American Board of Gastroenterology.
has conducted research on the pathogenesis of Crohn's disease, as well as on nutrient lipid absorption and the influence of aging on intestinal functions.